Showing 161 - 180 results of 130,148 for search '(( significant based cancer ) OR ( significant ((teer decrease) OR (a decrease)) ))', query time: 1.91s Refine Results
  1. 161
  2. 162
  3. 163
  4. 164

    Subgroup analysis of BUN based on pump type. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    “…The analysis showed that pulsatile perfusion led to a significant decrease in creatinine level [MD = −0.14, 95% CI (−0.24, −.04), P < 0.004], lactate level [MD = −8.21, 95% CI (−13.16, −3.25), P < 0.001], hospital stay [MD = −1.38, 95% CI (−2.51, −0.25), P = 0.016], ICU stay [MD = −0.47, 95% CI (−0.82, −0.13), P = 0.007], intubation time [MD = −3.73, 95% CI (−5.42, −2.04), P < 0.001], and increase in creatinine clearance [MD = 10.08, 95% CI (3.36, 16.80), P < 0.003]. …”
  5. 165

    Subgroup analysis of BUN based on surgery type. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    “…The analysis showed that pulsatile perfusion led to a significant decrease in creatinine level [MD = −0.14, 95% CI (−0.24, −.04), P < 0.004], lactate level [MD = −8.21, 95% CI (−13.16, −3.25), P < 0.001], hospital stay [MD = −1.38, 95% CI (−2.51, −0.25), P = 0.016], ICU stay [MD = −0.47, 95% CI (−0.82, −0.13), P = 0.007], intubation time [MD = −3.73, 95% CI (−5.42, −2.04), P < 0.001], and increase in creatinine clearance [MD = 10.08, 95% CI (3.36, 16.80), P < 0.003]. …”
  6. 166
  7. 167
  8. 168

    A total of 700 DEGs. by Wei He (131453)

    Published 2025
    Subjects:
  9. 169

    FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

    Published 2019
    “…<p>(A) Following 24 hours of treatment with FTY720, the viability of HuH6 cells measured using the alamarBlue cell viability assay was significantly decreased (LD<sub>50</sub> = 8.4 μM, p ≤ 0.05). …”
  10. 170
  11. 171
  12. 172
  13. 173
  14. 174
  15. 175

    Image_3_Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram.tif by Guodong Jing (13048956)

    Published 2022
    “…Objective<p>To develop and validate a multimodal MRI-based radiomics nomogram for predicting clinically significant prostate cancer (CS-PCa).…”
  16. 176

    Table_1_Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram.docx by Guodong Jing (13048956)

    Published 2022
    “…Objective<p>To develop and validate a multimodal MRI-based radiomics nomogram for predicting clinically significant prostate cancer (CS-PCa).…”
  17. 177

    Table_3_Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram.docx by Guodong Jing (13048956)

    Published 2022
    “…Objective<p>To develop and validate a multimodal MRI-based radiomics nomogram for predicting clinically significant prostate cancer (CS-PCa).…”
  18. 178

    Table_2_Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram.docx by Guodong Jing (13048956)

    Published 2022
    “…Objective<p>To develop and validate a multimodal MRI-based radiomics nomogram for predicting clinically significant prostate cancer (CS-PCa).…”
  19. 179

    Image_2_Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram.tif by Guodong Jing (13048956)

    Published 2022
    “…Objective<p>To develop and validate a multimodal MRI-based radiomics nomogram for predicting clinically significant prostate cancer (CS-PCa).…”
  20. 180

    Image_1_Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram.tif by Guodong Jing (13048956)

    Published 2022
    “…Objective<p>To develop and validate a multimodal MRI-based radiomics nomogram for predicting clinically significant prostate cancer (CS-PCa).…”